Transcranial magnetic stimulation (TMS) for schizophrenia

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 8, 2015, Pages

  Dougall, Nadine ^a   Maayan, Nicola ^b   Soares Weiser, Karla ^b   Mcdermott, Lisa M ^c   Mcintosh, Andrew ^d  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b Central Office   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

DEPRESSION; HALLUCINATION; HEADACHE; HUMAN; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TEMPOROPARIETAL JUNCTION; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; ADVERSE EFFECTS; HALLUCINATIONS; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIPSYCHOTIC AGENTS; HALLUCINATIONS; HEADACHE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84991230628     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006081.pub2     Document Type: Review

References (198)

1. Bagati D, Nizamie SH, Prakash R. Effect of augmentatory repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: randomized controlled study. Australian and New Zealand Journal of Psychiatry 2009;43(4):386-92. [MEDLINE: 19296295]
2. Barr MS, Farzan F, Rajji TK, Voineskos AN, Blumberger DM, Arenovich T, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biological Psychiatry 2013;73(6):510-7.
3. Barr MS, Farzan F, Tran LC, Fitzgerald PB, Daskalakis ZJ. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimulation 2011;3(5):337-46.
4. NCT01494623 . The effect of repetitive transcranial magnetic stimulation (rtms) on working memory. ClinicalTrials.gov/show/NCT01494623 2011 (accessed 25th July 2015).
5. Blumberger DM, Christensen BK, Zipursky RB, Moller B, Chen R, Fitzgerald PB, et al. MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations. Brain Stimulation 2012;5(4):577-85.
6. NCT01386918 . Repetitive transcranial magnetic stimulation for refractory auditory hallucinations in schizophrenia. clinicaltrials.gov/ct2/show/NCT01386918 2011 (accessed 25th July 2015).
7. Brunelin J, Poulet E, Bediou B, Kallel L, Dalery J, D'amato T, et al. Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophrenia Research 2006;81(1):41-5. [: EMBASE 2005578713]
8. Chinese Source Repetitive transcranial magnetic stimulation in the adjuvant treatment of patients with schizophrenia to explore the influence of eye movements and negative symptoms: a randomized, double-blind, pseudo-stimulus-control study
9. Cordes J, Thunker J, Agelink MW, Arends M, Mobascher A, Wobrock T, et al. Effects of 10 hz repetitive transcranial magnetic stimulation (rtms) on clinical global impression in chronic schizophrenia. Psychiatry Research 2010;177(1-2):32-6. [MEDLINE: 20378181]
10. Mittrach M, Thunker J, Winterer G, Agelink MW, Regenbrecht G, Arends M, et al. The tolerability of rtms treatment in schizophrenia with respect to cognitive function. Pharmacopsychiatry 2010;43(3):110-7.
11. NCT00169689 . Therapeutic and biological effects of high frequency repetitive transcranial magnetic stimulation (rTMS) in schizophrenia. www.clinicaltrials.gov 2005 (accessed 25th July 2015).
12. De Jesus DR, Gil A, Barbosa L, Lobato MI, Da Silva Magalhaes PV, De Souza Favalli GP, et al. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry Research 2011;188(2):203-7. [MEDLINE: BIOSIS:PREV201100512109]
13. Fitzgerald PB, Benitez J, Daskalakis JZ, Brown TL, Marston NA, De Castella A, et al. A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology 2005;25(4):358-62.
14. Fitzgerald PB, Herring S, Hoy K, McQueen S, Segrave R, Kulkarni J, et L. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimulation 2008;1(1):27-32.
15. Fitzgerald PB, Hoy K, Herring S, McQueen S, Karpinski A, Daskalakis ZZ. The use of rtms and tdcs in the treatment of the positive, negative and cognitive symptoms of schizophrenia. Australian and New Zealand Journal of Psychiatry 2010;1:16.
16. Chinese Source, Low-frequency repetitive transcranial magnetic stimulation treatment of schizophrenia and the effect of chronic auditory hallucinations follow-up study] Google Translate 2009;22(4):257-8.
17. Chinese Source, The effect of repetitive transcranial magnetic stimulation on serum prolactin levels and event-related potential P300 2009;19(2):84-7.
18. Chinese Source, [Repetitive transcranial magnetic stimulation on the negative symptoms of chronic schizophrenia soldiers and the efficacy of cognitive function] Google Translate. Sichuan Mental Health 2009;22(4):193-5.
19. Chinese Source, Low-frequency repetitive transcranial magnetic stimulation treatment of chronic auditory hallucinations of schizophrenia efficacy soldiers] Google Translate 2010;53(1):5-6.
20. Cordes J, Falkai P, Guse B, Hasan A, Schneider-Axmann T, Arends M, et al. Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study. European Archives of Psychiatry and Clinical Neuroscience 2009;259(Suppl 2):189-97. [MEDLINE: 19876678]
21. Guse B, Falkai P, Gruber O, Whalley H, Gibson L, Hasan A, et al. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls-a randomized placebo-controlled, double-blind fmri study. Behavioural Brain Research 2013;237(1):300-7.
22. NCT00783120 . Repetitive transcranial magnetic stimulation (rTMS) for the treatment of negative symptoms in schizophrenia. www.clinicaltrials.gov 2008 (accessed 25th July 2015).
23. Hao L, Hui L, Rui L, Jijun W. The analysis of curative effect of negative symptoms in schizophrenic patients after the treatment of repetitive transcranial magnetic stimulation (rTMS). Journal of Modern Electrophysiology 2008;15(3):134-7.
24. Hoffman RE, Gueorguieva R, Hawkins KA, Varanko M, Boutros NN, Wu Y, et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biological Psychiatry 2005;58(2):97-104.
25. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Archives of General Psychiatry 2003;60(1):49-56. [MEDLINE: 22399428;: 12511172]
26. NCT00004980 . Randomized study of repetitive magnetic stimulation of speech processing brain areas in schizophrenic patients who hear "voices". www.clinicaltrials.gov 2000 (accessed 25th July 2015).
27. NCT00042159 . TMS intervention development for auditory hallucinations. www.clinicaltrials.gov 2002 (accessed 25th July 2015).
28. Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal rTMS in schizophrenia. Nordic Journal of Psychiatry 2002; Vol. 56:19.
29. Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophrenia Bulletin 2004;30(2):429-34. [MEDLINE: 15279057;: EMBASE 2004274074]
30. Klein E, Kolsky Y, Puyerovsky M, Koren D, Chistyakov A, Feinsod M. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double blind sham controlled pilot study. Biological Psychiatry 1999;46(10):1451-4. [MEDLINE: 10578460;: EMBASE 1999401053]
31. Klirova M, Horacek J, Novak T, Cermak J, Tislerova B, Tintera J. Clinical response of neuronavigated repetitive-tms in the treatment of auditory hallucinations. European Neuropsychopharmacology 2010;1:304-5.
32. Klirova M, Horek J, Ermk J, Novk T, Tilerov B. Clinical response of neuronavigated rtms in the treatment of auditory hallucinations. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24-28; Lisbon Portugal. 2009:S773.
33. Lee S-H, Kim W, Chung Y-C, Jung K-H, Bahk W-M, Jun T-Y, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neuroscience Letters 2005;376(3):177-81. [MEDLINE: 15721217;: EMBASE 2005083871]
34. Liu R, Wang J, Liu H, Li H. Comparative study for influence of rTMS on cognitive function in schizophrenia 2008;20(5):257-60, 307.
35. Chinese Source. Low-frequency repetitive transcranial magnetic stimulation bdnf control of the level of impact on the sera of patients with schizophrenia 2011;24(03):196-9.
36. McIntosh AM, Semple D, Tasker K, Harrison LK, Owens DGC, Johnstone EC, et al. Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Research 2004;127(1-2):9-17.
37. McLoughlin D. Clinical effectiveness of repetitive transcranial magnetic stimulation (rTMS) for auditory hallucinations in schizophrenia- a randomised controlled trial. Unpublished report. 1994. [: 7th World Congress of Biological Psychiatry [CD-ROM]: Conifer, Excerpta Medica Medical Communications BV, 2001 S019-05]
38. McLoughlin DM, Mogg A, Purvis R, Eranti S, Brown R, Contell F, et al. Transcranial magnetic stimulation for negative symptoms in schizophrenia; a randomised pilot study. Biological Psychiatry 2006;59(8 Suppl):34S.
39. McLoughlin DM, Mogg A, Purvis R, Eranti S, Brown R, Contell F, et al. Transcranial magnetic stimulation for negative symptoms in schizophrenia; a randomised pilot study. Proceedings of the 61st Annual Convention of the Society of Biological Psychiatry; 2006 May 18-20; Toronto, Canada. Toronto, CANADA: Elsevier Science Inc, 2006:110.
40. Mogg A, Purvis R, Eranti S, Contell F, Taylor JP, Nicholson T, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: A randomized controlled pilot study. Schizophrenia Research 2005;93(1-3):221-8.
41. NCT00308997 . Transcranial magnetic stimulation guided by neuroimaging for patients with persistent "voices". www.clinicaltrials.gov 2006 (accessed 25th July 2015).
42. NCT00567281 . (Re-enrollment) Bilateral repetitive transcranial magnetic stimulation trial for auditory hallucinations. www.clinicaltrials.gov 2007 (accessed 25th July 2015).
43. Novak T, Horacek J, Mohr P, Kopecek M, Rodriguez M, Spaniel F, et al. The double-blind sham-controlled study of high-frequency rTMS (20Hz) fro negative symptoms in schizophrenia: a negative results. Neuroendocrinology Letters 2006;27(1-2):101-5.
44. Poulet E, Brunelin J, Bediou B, Bation R, Forgeard L, Dalery J, et al. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biological Psychiatry 2005;57(2):188-91. [MEDLINE: PUBMED 15652879;: CN-00513935]
45. Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Erratum to "Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study" [Schizophrenia Research 95 (1-3) (2007) 151-157] (DOI:101016/jschres200706019). Schizophrenia Research 2008;99:380-1.
46. Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophrenia Research 2007;95(1-3):151-7.
47. Prikryl R, Kasperek T, Kucerova H, Ustohal L, Venclikova S, Ceskova E, et al. Has high frequency repetitive transcranial magnetic stimulation therapeutic potential in schizophrenia?. 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP). 2008; Vol. 11:91.
48. Prikryl R, Ustohal L, Kasparek T, Kucerova H, Ceskova E, Skotakova S. Influencing negative symptoms of schizophrenia with repetitive transcranial magnetic stimulation: a pilot study. European Neuropsychopharmacology. Amsterdam: Elsevier, 2006; Vol. 16 Suppl.4:S444-5.
49. Chinese Source. Low-frequency repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations of schizophrenia randomized double-blind controlled study Google Translate. Chinese Mental Health Journal 2010;24(3):195-7, 205.
50. Ren Y-P, Zhou D-F, Cai Z-J, Huang Q, Lu L, Chen Q. Effects of high frequency repetitive transcranial magnetic stimulation on refractory negative symptom of schizophrenia: A double blind, randomized controlled trial. Chinese Mental Health Journal 2011;25(2):89-92.
51. Rosa MO, Gattaz WF, Rosa MA, Rumi DO, Tavares H, Myczkowski M, et al. Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. Journal of Clinical Psychiatry 2007; Vol. 68, issue 10:1528-32.
52. Rosenberg O, Gersner R, Klein LD, Kotler M, Zangen A, Dannon P. Deep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: A double-blind study. Annals of General Psychiatry 2012;11:13.
53. Saba G, Verdon CM, Kalalou K, Rocamora JF, Dumortier G, Benadhira R, et al. Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study. Journal of Psychiatric Research 2006;40(2):147-52.
54. Schneider A, Schneider T, Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: A 4-week randomized placebo controlled study. Brain Stimulation 2008;1(2):106-11.
55. Slotema CC, Blom JD, Hoek HW, Kahn RS, Sommer IE. The efficacy of low-frequency repetitive transcranial magnetic stimulation treatment for auditory verbal hallucinations may be low. Proceedings of the 163rd Annual Meeting of the American Psychiatric Association; 2010 May 22-26; New Orleans, LA. 2010.
56. Slotema CW, Blom JD, De Weijer AD, Diederen KM, Goekoop R, Looijestijn J, et al. Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biological Psychiatry 2011;69(5):450-6. [MEDLINE: BIOSIS:PREV201100154047]
57. Slotema CW, Blom JD, Hoek HW, Kahn RS, Sommer IE. Can low-frequency rtms really relieve medication-resistant auditory verbal hallucinations? Negative results from a large rct. Schizophrenia Research 2010;117(2-3):534. [MEDLINE: ISI:000276936801402]
58. Vercammen A, Knegtering H, Bruggeman R, Westenbroek HM, Jenner JA, Slooff CJ, et al. Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry 2010;1(1):15.
59. Vercammen A, Knegtering H, Bruggeman R, Westenbroek Hanneke M, Jenner JA, Slooff CJ, et al. Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophrenia Research 2009;114(1-3):172-9. [MEDLINE: 19679450]
60. Vercammen A, Knegtering H, Liemburg EJ, Den Boer JA, Aleman A. Functional connectivity of the temporo-parietal region in schizophrenia: Effects of rtms treatment of auditory hallucinations. Journal of Psychiatric Research 2010;44(11):725-31. [MEDLINE: 20189190]
61. NCT00736710 . rTMS effects on smoking cessation and cognition in schizophrenia. www.clinicaltrials.gov 2008 (accessed 25th July 2015).
62. Wing VC, Bacher I, Daskalakis ZJ, George T. A preliminary study of repetitive transcranial magnetic stimulation for smoking cessation in schizophrenia. Neuropsychopharmacology 2010;35:S163.
63. Wing VC, Bacher I, Daskalakis ZJ, George T. A preliminary study of repetitive transcranial magnetic stimulation for smoking cessation in schizophrenia. Proceedings of the 49th Annual Meeting of the American College of Neuropsychopharmacology; 2010 Dec 5-9; Miami, Florida. 2010.
64. Wing VC, Bacher I, Wu BS, Daskalakis ZJ, George TP. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophrenia Research 2012;139(1-3):264-6.
65. Chinese Source . Clinical study of the treatment of schizophrenia refractory auditory hallucinations low frequency repetitive transcranial magnetic stimulation 2011; Vol. 21, issue 03:177-80.
66. Chinese Source. Transcranial magnetic stimulation on prolactin levels in patients with schizophrenia 2010; Vol. 12, issue 06:512-4.
67. Chinese Source. Low-frequency repetitive transcranial magnetic stimulation on serum prolactin levels in patients with chronic schizophrenia 2011;24(03):192-5.
68. Chinese Source. Randomized, double-blind study of repetitive transcranial magnetic stimulation treatment of negative symptoms of schizophrenia 2010;22(05):262-5.
69. Zheng LN, Guo Q, Li H, Li C B, Wang JJ. Effects of repetitive transcranial magnetic stimulation with different paradigms on the cognitive function and psychotic symptoms of schizophrenia patients. Beijing Da Xue Xue Bao 2012;44:732-6.
70. ACTRN12611000731998 . Transcranial direct current stimulation (tdcs) treatment for auditory hallucinations and thinking problems in schizophrenia. www.anzctr.org.au 2010 (accessed 25th July 2015).
71. ACTRN12612000217808 . Non-invasive brain stimulation and working memory enhancement in schizophrenia and healthy controls: Investigating transcranial direct current stimulation (tdcs) and transcranial alternating current stimulation (tacs). www.anzctr.org.au/ACTRN12612000217808.aspx 2012 (accessed 25th July 2015).
72. ACTRN12612001112853 . Using transcranial direct current stimulation (tdcs) to improve working memory in schizophrenia and healthy controls: Investigating the role of current strength at three time points post stimulation. www.anzctr.org.au/ACTRN12612001112853.aspx 2012 (accessed 25th July 2015).
73. Alva G, Cohen E, Jin Y, Highum DM, Fleming K, Bunney WE, et al. Differential effects of high and low frequency RTMS in schizophrenia. Schizophrenia Research 2001;49(2, Suppl 1):219.
74. Arends M, Mobascher A, Kratz J, Brinkmeyer J, Jänner M, Agelink MW, et al. Left dorsolateral prefrontal high frequency repetitive transcranial magnetic stimulation (rtms) and cognition in schizophrenic patients. XIII World Congress of Psychiatry; 2005 10-15th Sept; Cairo, Egypt. 2005. [: P11.P065]
75. Benitez J, Fitzgerald PB, Marston N, De Castella AR, Kulkarni J. A double-blind sham controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Schizophrenia Bulletin 2005;31:509. [: 116185]
76. Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny M-F, et al. Examining transcranial direct-current stimulation (tdcs) as a treatment for hallucinations in schizophrenia. American Journal of Psychiatry 2012;169(7):719-24. [MEDLINE: BIOSIS:PREV201200520535]
77. Chibbaro G, Daniele M, Alagona G, Di Pasquale C, Cannavo M, Rapisarda V, et al. Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neuroscience Letters 2005;383(1-2):54-7. [: EMBASE: 2005252385]
78. Cohen E, Bernardo M, Masana J, Arrufat FJ, Navarro V, Valls-Sole J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. Journal of Neurology, Neurosurgery, and Psychiatry 1999;67(1):129-30.
79. Cordes J, Mittrach M, Kotrotsios G, Arends M, Wölwer W, Winterer G, et al. Effect of a treatment with 10 hz repetitive transcranial magnetic stimulation (rTMS) on the EEG alpha activity of schizophrenic patients. Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA. 2008.
80. D'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, Van der Linden JA, et al. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. Journal of Neuropsychiatry and Clinical Neuroscience 2002;14(1):77-9.
81. Daskalakis ZJ, Christensen BK, Chen R, Fitzgerald PB, Zipursky RB, Kapur S. Effect of antipsychotics on cortical inhibiition using transcranial magnetic stimulation. Psychopharmacology 2003;170(3):255-62.
82. Daskalakis Z. Repetitive transcranial magnetic stimulation (RTMS) in the neurophysiology and treatment of schizophrenia. Schizophrenia Bulletin 2007;33:402.
83. Davey NJ, Puri BK, Lewis HS, Lewis SW, Ellaway PH. Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry 1997;63(4):468-73.
84. Feinsod M, Kreinin B, Chistyakov A, Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depression and Anxiety 1998;7(2):65-8.
85. Fitzgerald PB, Brown TL, Marston NA, Oxley TJ, De Castella A, Daskalakis ZJ, et al. A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia. Psychiatry Research 2003;118(3):197-207.
86. Geller V, Grisaru N, Abarbanel JM, Lemberg T, Belmaker RH. Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Progressive Neuro-Psychopharmacology & Biological Psychiatry 1997;21(1):105-10.
87. Goyal N, Nizamie SH, Desarker P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. Journal of Neuropsychiatry and Clinical Neuroscience 2007;19(4):464-7.
88. Grenier S, Fouldrin G, Allio G, Opolczynski G, Thibaut F. Repetitive transcranial magnetic stimulation efficiency in treatment-resistant auditory hallucinations. Schizophrenia Research 2008;98:56.
89. Hajak G, Marienhagen J, Langguth B, Werner S, Binder H, Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychological Medicine 2004;34(7):1157-63.
90. Hasan A, Guse B, Heine Y, Heyer S, Schneider-Axmann T, Falkai P, et al. Effects of long-term prefrontal repetitive transcranial magnetic stimulation on motor-cortical excitability. European Archives of Psychiatry and Clinical Neuroscience 2010;1:52.
91. Hasey G. Repeated transcranial magnetic stimulation (rTMS) for severe depression. Stanley Foundation Research Programs 2000.
92. Hoffman RE, Berman RM, Roessler E, Belger A, Krystal JH, Charney DS. Low-frequency transcranial magnetic stimulation in patients reporting voices. 152nd Annual Meeting of the American Psychiatric Association; 1999 May 15-20; Washington DC, USA. 1999. [MEDLINE: 91114065]
93. Hoffman R, Boutros N, Preda A, Rachid F, Krystal J. One hertz repetitive transcranial magnetic stimulation reduces auditory hallucinations in patients with schizophrenia. Proceedings of the 7th World Congress of Biological Psychiatry. 2001 Jul 1-6; Berlin, Germany.
94. Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney-DS . Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 2000;355(9209):1073-5. [MEDLINE: 10744097]
95. Hoffman RE, Hawkins KA, Anderson AW, Buchanan R, Wu K, Hampson M, et al. One hertz repetitive transcranial magnetic stimulation delivered to brain areas underlying speech perception reduces persistent auditory hallucinations. Schizophrenia Research 2003;60(1, Suppl 1):285-6. [MEDLINE: 22399428;: 12511172]
96. Hoffman RE, Hampson M, Wu K, Anderson AW, Gore JC, Buchanan RJ, et al. Proving the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cerebral Cortex 2007;17(11):2733-43.
97. Jandl M, Bittner R, Sack A, Weber B, Gunther T, Pieschl D, et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. Journal of Neural Transmission 2005;112(7):955-67.
98. Jandl M, Steyer J, Weber M, Linden DE, Rothmeier J, Maurer K, et al. Treating auditory hallucination by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology 2006;53(2):63-9.
99. Jandl M, Kaschka WP. Treatment of therapy-resistant auditory verbal hallucinations in schizophrenia patients by repetitive transcranial magnetic stimulation. In: Elkis H, Meltzer H editor(s). Therapy-Resistant Schizophrenia. Basel: Karger, 2010:177-94.
100. Jin Y, Potkin SG, Huerta S, Alva G, Kang P, Bunney WE. EEG-guided RTMS improves negative symptoms in schizophrenia. Schizophrenia Research 2003;60(1, Suppl 1):287-8. [DOI: S0920996403804735; MEDLINE: 22399428]
101. Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (TMS) on the negative symptoms of schizophrenia. Schizophrenia Bulletin 2006;32(3):556-61.
102. Jin Y, Kemp AS, Huang Y, Thai TM, Liu Z, Xu W, et al. Alpha EEG guided TMS in schizophrenia. Brain Stimulation 2012;5(4):560-8.
103. Levit-Binnun N, Handzy NZ, Moses E, Modai I, Peled A. Transcranial Magnetic Stimulation at M1 disrupts cognitive networks in schizophrenia. Schizophrenia Research 2007;93(1-3):334-44.
104. Lifshitz K, Harper P. A trial of transcranial polarization in chronic schizophrenics. British Journal of Psychiatry 1968;114(510):635-7. [MEDLINE: 68276552]
105. Loo CK, Sainsbury K, Mitchell P, Hadzi-Pavlovic D, Sachdev PS. A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations. Psychological Medicine 2010;40(4):541-6. [MEDLINE: ISI:000276575300002]
106. Luber B, Stanford AD, Malaspina D, Lisanby SH. Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation. Biological Psychiatry 2007;62(7):793-9.
107. Mattai A, Miller R, Weisinger B, Greenstein D, Bakalar J, Tossell J, et al. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia. Brain Stimulation 2011;4(4):275-80. [MEDLINE: 22032743]
108. Mobascher A, Agelink MW, Arends M, Brinkmeyer J, Jaenner M, Henning U, et al. Influence of high frequency repetitive transcranial magnetic stimulation (rTMS) on cardiovagal modulation and monoaminergic activity in schizophrenia. Schizophrenia Bulletin 2005;31:514.
109. NCT00517075 . Treatment of negative symptoms of schizophrenia with transcranial magnetic stimulation (TMS). www.clinicaltrials.gov 2007 (accessed 25th July 2015).
110. NCT00757497 . Transcranial direct current brain stimulation to treat patients with childhood-onset schizophrenia. www.clinicaltrials.gov 2008 (accessed 25th July 2015).
111. NCT00870909 . Transcranial direct current stimulation (tDCS) and hallucinations in schizophrenia. www.clinicaltrials.gov 2009 (accessed 25th July 2015).
112. NCT01041274 . DECIFER: DEpression and Citalopram In First Episode Recovery. www.clinicaltrials.gov 2009 (accessed 25th July 2015).
113. NCT01378078 . Transcranial direct current stimulation (tdcs) for treatment of negative syndrome in patients with schizophrenia. ClinicalTrials.gov/show/NCT01378078 2011 (accessed 25th July 2015).
114. NCT01595503 . Transcranial magnetic stimulation for the treatment of auditory hallucinations in schizophrenia. ClinicalTrials.gov/show/NCT01595503 2012 (accessed 25th July 2015).
115. NCT01607840 . Effects of transcranial direct current stimulation in individuals with schizophrenia. ClinicalTrials.gov/show/NCT01607840 2012 (accessed 25th July 2015).
116. NCT01620086 . Effect of repetitive transcranial magnetic stimulation on resting state brain activity in schizophrenia. ClinicalTrials.gov/show/NCT01620086 2012 (accessed 25th July 2015).
117. NCT01623726 . Transcranial direct current stimulation (tdcs) as therapeutical strategy for negative symptoms in schizophrenia. ClinicalTrials.gov/show/NCT01623726 2012 (accessed 25th July 2015).
118. Potkin S. A randomized, sham-controlled trial of repetitive transcranial magnetic stimulation in schizophrenia. Stanley Foundation Research Programs 2000.
119. Puri BK, Davey NJ, Lewis SW. The effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenic patients. Schizophrenia Research 1996;18(2):234.
120. Huber TJ, Schneider U, Rollnik J. Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia. Psychiatry Research 2003;120(1):103-5.
121. Rollnik JD, Huber TJ, Mogk H, Siggelkow S, Kropp S, Dengler R, et al. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport 2000;11(18):4013-5. [: Biological Abstracts 00073700]
122. Rushby JA, Loo C, Weickert CS, Weickert TW. Effects of transcranial direct current stimulation on probabilistic feedback learning in people with schizophrenia. Schizophrenia Research 2010;117(2-3):177.
123. Sachdev P, Loo C, Mitchell P, Malhi G. Transcranial Magnetic Stimulation for the deficit syndrome of schizophrenia: A pilot investigation. Psychiatry and Clinical Neurosciences 2005;59(3):354-7.
124. Schneider A. A 2-week double-blind, randomized controlled trial of repetitive transcranial magnetic stimulation in schizophrenia. Stanley Foundation Research Programs 2001.
125. Schonfeldt-Lecuona C, Gron G, Walter H, Buchler N, Wunderlich A, Spitzer M, et al. Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport 2004;15(10):1669-73. [: CN-00516247]
126. Slotema CW, Blom JD, De Weijer AD, Hoek HW, Sommer IE. Priming does not enhance the efficacy of 1 hertz repetitive transcranial magnetic stimulation for the treatment of auditory verbal hallucinations: results of a randomized controlled study. Brain Stimulation 2012;5(4):554-9.
127. Weickert TW, Rushby JA, Vercammen A, Weickert CS, Loo CK. Effects of transcranial direct current stimulation on probabilistic feedback learning in people with schizophrenia. Australian and New Zealand Journal of Psychiatry 2010;1(1):16-7.
128. Xu W-J, Jin YO, Huang Y, Liu Z, He H, Jin C. Double-blind control trial of alpha electroencephalogram-guided transcranial magnetic stimulation treatment for schizophrenia. Chinese Journal of Clinical Rehabilitation 2006;10(46):22-4.
129. Yu H-C, Liao K-K, Chang T-J, Tsai S-J. Transcranial magnetic stimulation in schizophrenia. Americal Journal of Psychiatry 2002;159(3):494-5.
130. Mohr P, Rodriguez M, Novak T, Kopecek M, Horacek J, Hendrychova Y, et al. Repetitive transcranial magnetic stimulation and rehabilitation of cognitive functions in schizophrenia. European Psychiatry 2007;22:S127.
131. Mohr P, Rodriguez M, Novak T, Kopecek M, Horacek J, Hendrychova Y, et al. Repetitive transcranial magnetic stimulation and rehabilitation of cognitive functions in schizophrenia. Psychiatrie (Stuttgart, Germany) 2006;10:7-15.
132. Dlabac-de Lange J, Aleman A. Effect of high frequency rTMS on negative symptoms and cognitive functioning in schizophrenia. www.trialregister.nl/trialreg/index.asp 2008 (accessed 25th July 2015).
133. Ebmeier K. TMS and auditory hallucination in schizophrenia. National Research Register 2001.
134. Hunter M. A double-blind randomised controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of persistent auditory hallucinations in schizophrenia. www.controlled-trials.com 2003 (accessed 25th July 2015).
135. IRCT138903254191N1 . The comparison of effectiveness of repetitive tms and itbs on negative symptoms and cognition in patients with schizophrenia:A study randomized and double blind. www.irct.ir/ 2011 (accessed 25th July 2015).
136. ISRCTN61109178 . Transcranial magnetic stimulation (tms) treatment study in auditory verbal hallucinations: A randomised controlled trial. isrctn.org/ISRCTN61109178 2012 (accessed 25th July 2015).
137. Lee KH. Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation. www.controlled-trials.com 2007 (accessed 25th July 2015).
138. NCT00186771 . Transcranial magnetic stimulation used to treat auditory hallucinations in schizophrenia. www.clinicaltrials.gov 2005 (accessed 25th July 2015).
139. NCT00685321 . Tolerability, safety and efficacy of the h1-coil deep transcranial magnetic stimulation in subjects with negative symptoms and cognitive deficits of schizophrenia. www.clinicaltrials.gov 2008 (accessed 25th July 2015).
140. NCT00763841 . Transcranial magnetic stimulation (TMS) for treatment of auditory hallucinations. www.clinicaltrials.gov 2008 (accessed 25th July 2015).
141. NCT00875498 . Intermittent theta burst stimulation (iTBS) for the treatment of negative symptoms in schizophrenia. www.clinicaltrials.gov 2009 (accessed 25th July 2015).
142. NCT01015001 . Effects of low frequency repetitive transcranial magnetic stimulation (rTMS) over temporoparietal cortex on the quality of life of refractory schizophrenic patients with auditory hallucinations. www.clinicaltrials.gov 2009 (accessed 25th July 2015).
143. NCT01022489 . High frequency repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: a randomized controlled study. www.clinicaltrials.gov 2009 (accessed 25th July 2015).
144. NCT01315587 . Repetitive transcranial magnetic stimulation and intermittent theta burst (itbs) in schizophrenia. ClinicalTrials.gov/show/NCT01315587 2011 (accessed 25th July 2015).
145. NCT01370291 . Repetitive transcranial magnetic stimulation for first-episode schizophrenia patients. ClinicalTrials.gov/show/NCT01370291 2011 (accessed 25th July 2015).
146. NCT01512290 . Theta burst transcranial magnetic stimulation as treatment for auditory verbal hallucinations. ClinicalTrials.gov/show/NCT01512290 2012 (accessed 25th July 2015).
147. NCT01523730 . Effects of rtms on cigarette smoking and cognition in schizophrenia. ClinicalTrials.gov/show/NCT01523730 2012 (accessed 25th July 2015).
148. NCT01551979 . Therapeutic efficacy of transcranial magnetic stimulation in schizophrenia. ClinicalTrials.gov/show/NCT01551979 2012 (accessed 25th July 2015).
149. Vercammen A, Aleman A. Treatment of hallucinated "voices" with repetitive transcranial magnetic stimulation: mechanism and efficacy. www.trialregister.nl/trialreg/index.asp 2009 (accessed 25th July 2015).
150. Altman DG, Bland JM. Statistics notes: detecting skewness from summary information. BMJ 1996;313(7066):1200.
151. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Iowa: University of Iowa, 1983.
152. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, Iowa: Univ. of Iowa, 1984.
153. American Psychiatric Association. Global assessment of functioning. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: American Psychiatric Association, 1987.
154. Barker AT. The history and basic principles of magnetic nerve stimulation. In: Pascual-Leone A, Davey N, Rothwell J, Wassermann EM, Puri BK editor(s). Handbook of Transcranial Magnetic Stimulation. 1st Edition. New York: Oxford University Press, 2002:3-17.
155. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
156. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-11.
157. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48(5):1398-403.
158. Chouinard PA, Van der Werf YD, Leonard G, Paus T. Modulating neural networks with transcranial magnetic stimulation applied over the dorsal premotor and primary motor cortices. Journal of Neurophysiology 2003;90(2):1071-83.
159. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa. 2000.
160. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. in: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
161. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale--preliminary report. Psychopharmacol Bulletin 1973;9(1):13-28.
162. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
163. Dlabac-de Lange J, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulatoin for negative symptoms of schizophrenia: review and meta-Analysis. Journal of Clinical Psychiatry 2010;71(4):411-8.
164. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971-80.
165. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
166. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials:methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [PUBMED: 11914310]
167. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin 1993;29(2):321-6.
168. Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophrenia Research 2009;108(1-3):11-24.
169. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7-10.
170. Geffen GM, Butterworth P, Forrester GM, Geffen LB. Auditory verbal learning test components as measures of the severity of closed-head injury. Brain Injury 1994;8(5):405-11.
171. Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876-83.
172. Guy U. Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology. National Institute of Mental Health, 1976.
173. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychological Medicine 1999;29(4):879-89.
174. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967;6(4):278-96.
175. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
176. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
177. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
178. Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS) manual. Positive and negative syndrome scale (PANSS) manual. North Tonawanda, NY: Multi-Health Systems, 1986.
179. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
180. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856]
181. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
182. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and across-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica. Supplementum 1987;334:1-100.
183. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52. [PUBMED: 8932886]
184. Matheson SL, Green MJ, Loo C, Carr VJ. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: a systematic meta-review. Schizophrenia Research 2010;118(1-3):201-10.
185. Matheson SL, Green MJ, Loo C, Carr VJ. A change in the conclusions of a recent systematic meta-review: Repetitive transcranial magnetic stimulation is effective for the negative symptoms of schizophrenia. Schizophrenia Research 2010;122(1-3):276-7.
186. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-89.
187. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799-812.
188. Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. Journal of Clinical Neurophysiology 1998;15(4):333-4.
189. Rey A. L'Examen Clinique en Psychologie. Paris: Presses Universitaires de France, 1964.
190. Rosenberg SJ, Ryan JJ, Prifitera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. Journal of Clinical Psychology 1984;40(3):785-7.
191. Saba G, Verdon CM, Kalalou K, Rocamora JF, Dumortier G, Benadhira R, Stamatiadis L, Vicaut E, Lipski H, Januel D. Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: A double blind sham controlled study. Journal of Psychiatric Research 2006;40(2):147-52.
192. Sackeim HA, Ross FR, Hopkins N, Calev L, Devanand DP. Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convulsive Therapy 1987;3(2):100-110.
193. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Chichester: John Wiley & Son.
194. Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Archives of General Psychiatry 2000;57:1033-8.
195. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG. Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75.
196. Weinberger DR, Berman KF. Prefrontal function in schizophrenia: confounds and controversies. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 1996;351(1346):1495-503.
197. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.
198. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965;12:63-70.